This HTML5 document contains 106 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q84884100
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в серпні 2011 scientific article published on 31 August 2011 wetenschappelijk artikel im August 2011 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu n'agostu de 2011
p:P577
wds:Q84884100-CE1A048C-5C91-47C5-9BEC-7E7AE570B995
wdt:P577
2011-08-31T00:00:00Z
p:P2860
wds:Q84884100-4F915058-28E1-43DE-85B1-69A314C28CD3 wds:Q84884100-57B205FD-BFA7-4DBE-A875-17D4B6DE0EA5 wds:Q84884100-1DD0DD34-145B-4E71-815D-4CA255BB226A wds:Q84884100-2024C4F6-A6C3-457F-9945-AF4EA485C25E wds:Q84884100-20CE7EEC-56EF-4C9F-B35C-D18F85B1EDD0 wds:Q84884100-3CFE23CA-5782-407C-8D8D-916354D03387 wds:Q84884100-8C3BBBD1-F5D3-4C56-9FBC-BB28E7F8320A wds:Q84884100-98AB125C-8304-4080-9AD4-D1C20C1FC63F wds:Q84884100-A4AE50D4-8353-439C-9989-0F1E527AF949 wds:Q84884100-B15CF2F3-F329-4336-A907-C815C5BEEE54 wds:Q84884100-B7C49E14-1BD7-41CA-8B33-D6DD3CD0356B wds:Q84884100-BB38B3F3-E657-468B-9FAA-B0393FA3E7ED wds:Q84884100-C5823D2E-FA48-4BBD-BA39-5E379F549657 wds:Q84884100-72DC1046-F840-4D27-82B5-02224280F48D wds:Q84884100-7652A25D-11C5-4E0F-A09E-BBD942210626 wds:Q84884100-78BA3688-47E6-494B-B2AF-34205FA773BC wds:Q84884100-792FCCF8-6B58-4A87-8A69-E64DEBD1B403 wds:Q84884100-7D3C2E6A-A8CC-4A8B-B33E-6200DF55598D wds:Q84884100-7F53534B-B223-47C0-953B-7BE6E28DAC42 wds:Q84884100-F6A063BF-6E6C-424C-B26B-3E692E485E97 wds:Q84884100-FE64FB96-C477-4AB7-A04A-1982EE231D8D wds:Q84884100-CD06DAC8-720B-4406-92B7-EB48E46BBF3F wds:Q84884100-D332E004-58B0-4BBF-A093-4018C5DDBA62 wds:Q84884100-EEFCD905-3415-47F3-B46D-A2613053CBCE wds:Q84884100-067AA56D-9306-4CBA-AB94-8A93A92BB2D9 wds:Q84884100-14B51D2D-074A-47E1-840A-E2E7065544B5 wds:Q84884100-1C988C0B-B0D4-41EF-B858-E211FE550BCC wds:Q84884100-4C32068D-20B7-45C2-B7CD-60C9C44B1BA8 wds:Q84884100-4F1F7778-7E69-4B6A-AEDE-F306156E8019
wdt:P2860
wd:Q37228015 wd:Q45839491 wd:Q46848035 wd:Q44456515 wd:Q28273764 wd:Q46842071 wd:Q28144133 wd:Q37720114 wd:Q52473747 wd:Q72142082 wd:Q45021389 wd:Q41219727 wd:Q41753210 wd:Q36472172 wd:Q69535436 wd:Q35865172 wd:Q44117264 wd:Q46879499 wd:Q35149566 wd:Q42942311 wd:Q37766268 wd:Q37759053 wd:Q44704337 wd:Q79731346 wd:Q33735269 wd:Q35011242 wd:Q34611908 wd:Q33252737 wd:Q37785529
p:P2093
wds:Q84884100-D4132173-A85B-46FC-89F2-33EC3CE74B9D wds:Q84884100-7BF69095-070A-467D-B9D0-7A583D68AEA1 wds:Q84884100-4A242A9E-0782-43E9-AFD0-22E6ABF55886 wds:Q84884100-2AFC021D-6501-465B-8672-040257833672 wds:Q84884100-2606EB5A-60D4-401E-BFE3-85B590F0A3C7
wdt:P2093
Lorraine Yurkewicz Reetta Kälviäinen Martin J Brodie Lloyd E Knapp Jerry Weaver
rdfs:label
Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial
skos:prefLabel
Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial
schema:name
Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial
p:P50
wds:Q84884100-F1273E90-6630-44C2-BC2C-7AC1D5B82E7B
wdt:P50
wd:Q39024955
p:P1476
wds:Q84884100-F9CAB1F2-F383-412F-A125-7DD33226542F
wdt:P1476
Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial
p:P304
wds:Q84884100-DD6B2C8F-9141-4636-9E9F-2BB9BF5F8F6A
wdt:P304
881-890
p:P31
wds:Q84884100-35EF6BF4-EEB9-483B-82D6-F69936F30A68
wdt:P31
wd:Q13442814
p:P921
wds:Q84884100-87292504-342D-4652-B143-1301D45CDC09 wds:Q84884100-91A437AA-1CA7-4DF0-AB16-B2CF000A7C11
wdt:P921
wd:Q410346 wd:Q42824827
p:P698
wds:Q84884100-60D6A218-B18F-4327-9B6F-230289112330
wdtn:P698
n12:21889410
wdt:P698
21889410
p:P1433
wds:Q84884100-27DABC60-5358-49F3-933F-D77DC964C2BC
wdt:P1433
wd:Q15755067
p:P433
wds:Q84884100-6F4E0DA3-279E-4722-98AE-6E8FB3775324
p:P478
wds:Q84884100-61DFFD79-A39F-4EF6-A36D-BC8B8A25FC60
wdt:P433
10
wdt:P478
10
p:P356
wds:Q84884100-D5AA927E-1BE2-431A-8FFF-4BAA1A78EF1E
wdtn:P356
n9:S1474-4422(11)70154-5
wdt:P356
10.1016/S1474-4422(11)70154-5